A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis

The etiology of sporadic human chronic inflammatory diseases remains mostly unknown. To fill this gap, we developed a strategy that simultaneously integrates blood leukocyte responses to innate stimuli at the transcriptional, cellular, and secreted protein levels. When applied to systemic juvenile idiopathic arthritis (sJIA), an autoinflammatory disease of unknown etiology, this approach identified gene sets associated with specific cytokine environments and activated leukocyte subsets. During disease remission and off treatment, sJIA patients displayed dysregulated responses to TLR4, TLR8, and TLR7 stimulation. Isolated sJIA monocytes underexpressed the IL-1 inhibitor aryl hydrocarbon receptor (AHR) at baseline and accumulated higher levels of intracellular IL-1&bgr; after stimulation. Supporting the demonstration that AHR down-regulation skews monocytes toward macrophage differentiation, sJIA monocytes differentiated in vitro toward macrophages, away from the dendritic cell phenotype. This might contribute to the increased incidence of macrophage activation syndrome in these patients. Integrated analysis of high-dimensional data can thus unravel immune alterations predisposing to complex inflammatory diseases.

[1]  T. Lehman,et al.  Systemic Arthritis in Children: A Review of Clinical Presentation and Treatment , 2011, International journal of inflammation.

[2]  M. Colonna,et al.  Aryl hydrocarbon receptor: Linking environment to immunity. , 2015, Seminars in immunology.

[3]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[4]  V. Pascual,et al.  Assessing the human immune system through blood transcriptomics , 2010, BMC Biology.

[5]  E. Giannini,et al.  Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.

[6]  R. Cron,et al.  Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment , 2012, Genes and Immunity.

[7]  Y. Fujii‐Kuriyama,et al.  Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses , 2009, The Journal of experimental medicine.

[8]  M. Geffard,et al.  Aryl hydrocarbon receptor control of a disease tolerance defence pathway , 2014, Nature.

[9]  M. Hedger,et al.  Activin and related proteins in inflammation: not just interested bystanders. , 2009, Cytokine & growth factor reviews.

[10]  A. Ivetic Signals regulating L-selectin-dependent leucocyte adhesion and transmigration. , 2013, The international journal of biochemistry & cell biology.

[11]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[12]  Naděžda Brdičková,et al.  CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs , 2006, Nature.

[13]  C. Sandborg,et al.  Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis , 2014, Arthritis & rheumatology.

[14]  Pedro Romero,et al.  Type I interferon inhibits interleukin-1 production and inflammasome activation. , 2011, Immunity.

[15]  R. Goldbach-Mansky,et al.  IL-1 blockade in autoinflammatory syndromes. , 2014, Annual review of medicine.

[16]  F. Gonzalez,et al.  Aryl hydrocarbon receptor influences nitric oxide and arginine production and alters M1/M2 macrophage polarization. , 2016, Life sciences.

[17]  A. Rubartelli,et al.  The secretion of IL-1β and options for release. , 2013, Seminars in immunology.

[18]  Martin Vingron,et al.  PASTAA: identifying transcription factors associated with sets of co-regulated genes , 2008, Bioinform..

[19]  J. Cyster,et al.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. , 2012, Annual review of immunology.

[20]  E. Schadt,et al.  Unifying immunology with informatics and multiscale biology , 2014, Nature Immunology.

[21]  V. Pascual,et al.  RNA recognition by human TLR8 can lead to autoimmune inflammation , 2013, The Journal of experimental medicine.

[22]  V. Pascual,et al.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade , 2005, The Journal of experimental medicine.

[23]  E. Marcotte,et al.  Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.

[24]  V. Pascual,et al.  A genomic approach to human autoimmune diseases. , 2010, Annual review of immunology.

[25]  C. Coch,et al.  A Human In Vitro Whole Blood Assay to Predict the Systemic Cytokine Response to Therapeutic Oligonucleotides Including siRNA , 2013, PloS one.

[26]  Naděžda Brdičková,et al.  CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. , 2006, Nature.

[27]  B. Stockinger,et al.  The aryl hydrocarbon receptor: multitasking in the immune system. , 2014, Annual review of immunology.

[28]  Simon Yu,et al.  INTERFEROME v2.0: an updated database of annotated interferon-regulated genes , 2012, Nucleic Acids Res..

[29]  Virginia Pascual,et al.  Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade , 2009, The Journal of Experimental Medicine.

[30]  Z. Sułowska,et al.  Spontaneous Apoptosis of Neutrophils in Whole Blood and its Relation to Apoptosis Gene Proteins , 2000, Scandinavian journal of immunology.

[31]  T. Ideker,et al.  A decade of systems biology. , 2010, Annual review of cell and developmental biology.

[32]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[33]  Prahlad T. Ram,et al.  Cancer Systems Biology: a peek into the future of patient care? , 2014, Nature Reviews Clinical Oncology.

[34]  Vincent Rouilly,et al.  Standardized Whole-Blood Transcriptional Profiling Enables the Deconvolution of Complex Induced Immune Responses. , 2016, Cell reports.

[35]  C. Wouters,et al.  Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. , 2012, The New England journal of medicine.

[36]  C. Wouters,et al.  Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients , 2014, Arthritis & rheumatology.

[37]  Vincent Rouilly,et al.  Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli. , 2014, Immunity.

[38]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[39]  N Baldwin,et al.  A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4 , 2014, Nature Immunology.

[40]  M. Kizaki,et al.  Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[41]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[42]  A. Horne,et al.  Macrophage activation syndrome in the era of biologic therapy , 2016, Nature Reviews Rheumatology.

[43]  A. Begovich,et al.  Alternative activation in systemic juvenile idiopathic arthritis monocytes. , 2012, Clinical immunology.

[44]  N. Hacohen,et al.  Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus Macrophages. , 2017, Immunity.

[45]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[46]  W. Huai,et al.  Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription , 2014, Nature Communications.

[47]  Virginia Pascual,et al.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.

[48]  Emily A. Stevens,et al.  The Aryl Hydrocarbon Receptor Signaling Pathway Is Modified through Interactions with a Kelch Protein , 2006, Molecular Pharmacology.

[49]  E. Wherry,et al.  Integrating genomic signatures for immunologic discovery. , 2010, Immunity.

[50]  Paul Landais,et al.  Extended Report , 2022 .

[51]  V. Pascual,et al.  Identification of the Key Differential Transcriptional Responses of Human Whole Blood Following TLR2 or TLR4 Ligation In-Vitro , 2014, PloS one.

[52]  Sean C. Bendall,et al.  Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus. , 2015, The Journal of allergy and clinical immunology.